These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19407366)

  • 1. Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker.
    Olofsson MH; Cummings J; Fayad W; Brnjic S; Herrmann R; Berndtsson M; Hodgkinson C; Dean E; Odedra R; Wilkinson RW; Mundt KE; Busk M; Dive C; Linder S
    Cancer Biomark; 2009; 5(3):117-25. PubMed ID: 19407366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of cytokeratin-based biomarkers for pharmacodynamic studies.
    Linder S; Olofsson MH; Herrmann R; Ulukaya E
    Expert Rev Mol Diagn; 2010 Apr; 10(3):353-9. PubMed ID: 20370591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
    Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
    Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients.
    Ausch C; Buxhofer-Ausch V; Olszewski U; Hinterberger W; Ogris E; Schiessel R; Hamilton G
    Eur J Surg Oncol; 2009 Nov; 35(11):1164-8. PubMed ID: 19254831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.
    Cummings J; Ward TH; LaCasse E; Lefebvre C; St-Jean M; Durkin J; Ranson M; Dive C
    Br J Cancer; 2005 Feb; 92(3):532-8. PubMed ID: 15685240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of 3,5,4'-trimethoxystilbene in COLO 205 cells and xenografts in SCID mice.
    Pan MH; Gao JH; Lai CS; Wang YJ; Chen WM; Lo CY; Wang M; Dushenkov S; Ho CT
    Mol Carcinog; 2008 Mar; 47(3):184-96. PubMed ID: 18085528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma.
    Cummings J; Ranson M; Butt F; Moore D; Dive C
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):921-4. PubMed ID: 17333190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.
    Yip KW; Mao X; Au PY; Hedley DW; Chow S; Dalili S; Mocanu JD; Bastianutto C; Schimmer A; Liu FF
    Clin Cancer Res; 2006 Sep; 12(18):5557-69. PubMed ID: 17000693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy.
    Olofsson MH; Ueno T; Pan Y; Xu R; Cai F; van der Kuip H; Muerdter TE; Sonnenberg M; Aulitzky WE; Schwarz S; Andersson E; Shoshan MC; Havelka AM; Toi M; Linder S
    Clin Cancer Res; 2007 Jun; 13(11):3198-206. PubMed ID: 17545523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levels of caspase-cleaved cytokeratin 18 are elevated in serum from patients with lung cancer and helpful to predict the survival.
    Ulukaya E; Yilmaztepe A; Akgoz S; Linder S; Karadag M
    Lung Cancer; 2007 Jun; 56(3):399-404. PubMed ID: 17316892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts.
    Duan WR; Garner DS; Williams SD; Funckes-Shippy CL; Spath IS; Blomme EA
    J Pathol; 2003 Feb; 199(2):221-8. PubMed ID: 12533835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.
    Cummings J; Ranson M; Lacasse E; Ganganagari JR; St-Jean M; Jayson G; Durkin J; Dive C
    Br J Cancer; 2006 Jul; 95(1):42-8. PubMed ID: 16804528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential use of cetrimonium bromide as an apoptosis-promoting anticancer agent for head and neck cancer.
    Ito E; Yip KW; Katz D; Fonseca SB; Hedley DW; Chow S; Xu GW; Wood TE; Bastianutto C; Schimmer AD; Kelley SO; Liu FF
    Mol Pharmacol; 2009 Nov; 76(5):969-83. PubMed ID: 19654225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of epithelial cell caspase activation via detection of durable keratin fragment formation.
    Tao GZ; Li DH; Zhou Q; Toivola DM; Strnad P; Sandesara N; Cheung RC; Hong A; Omary MB
    J Pathol; 2008 Jun; 215(2):164-74. PubMed ID: 18393369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker.
    Linder S; Havelka AM; Ueno T; Shoshan MC
    Cancer Lett; 2004 Oct; 214(1):1-9. PubMed ID: 15331168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin markers come of age.
    Linder S
    Tumour Biol; 2007; 28(4):189-95. PubMed ID: 17717426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.
    Al-Saffar NM; Troy H; Ramírez de Molina A; Jackson LE; Madhu B; Griffiths JR; Leach MO; Workman P; Lacal JC; Judson IR; Chung YL
    Cancer Res; 2006 Jan; 66(1):427-34. PubMed ID: 16397258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.
    de Haas EC; di Pietro A; Simpson KL; Meijer C; Suurmeijer AJ; Lancashire LJ; Cummings J; de Jong S; de Vries EG; Dive C; Gietema JA
    Neoplasia; 2008 Oct; 10(10):1041-8. PubMed ID: 18813353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum M30 levels are associated with survival in advanced gastric carcinoma patients.
    Yaman E; Coskun U; Sancak B; Buyukberber S; Ozturk B; Benekli M
    Int Immunopharmacol; 2010 Jul; 10(7):719-22. PubMed ID: 20362077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.